Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.72 EUR | +0.04% | 0.00% | +99.12% |
Apr. 11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
Apr. 11 | Trending : Novartis Begins Tender Offer for MorphoSys Shares | DJ |
Sales 2024 * | 252M 269M | Sales 2025 * | 325M 347M | Capitalization | 2.55B 2.73B |
---|---|---|---|---|---|
Net income 2024 * | -182M -195M | Net income 2025 * | -115M -123M | EV / Sales 2024 * | 9.71 x |
Net cash position 2024 * | 106M 113M | Net cash position 2025 * | 241M 257M | EV / Sales 2025 * | 7.11 x |
P/E ratio 2024 * |
-16
x | P/E ratio 2025 * |
-32.8
x | Employees | 524 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.59% |
Latest transcript on MorphoSys AG
1 day | +0.04% | ||
Current month | +0.74% | ||
1 month | +0.80% | ||
3 months | +88.42% | ||
6 months | +146.09% | ||
Current year | +99.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 19-08-31 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 23-08-06 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 18-05-16 |
Director/Board Member | 67 | 18-05-16 | |
Marc Cluzel
CHM | Chairman | 69 | 12-05-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.44% | 125 M€ | -.--% | ||
0.80% | 17 M€ | -.--% | - | |
0.11% | 2 M€ | -.--% | ||
0.02% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 67.7 | 0.00% | 35 019 |
24-04-24 | 67.7 | -0.07% | 63,222 |
24-04-23 | 67.75 | 0.00% | 55,900 |
24-04-22 | 67.75 | +0.07% | 131,745 |
24-04-19 | 67.7 | 0.00% | 59,669 |
Delayed Quote Xetra, April 25, 2024 at 09:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.12% | 2.72B | |
+1.43% | 43.84B | |
+5.61% | 41.68B | |
+45.04% | 41.25B | |
-10.92% | 27.04B | |
+7.90% | 25.53B | |
-25.34% | 18.18B | |
-1.97% | 12.29B | |
+25.99% | 12.29B | |
+6.60% | 11.15B |
- Stock Market
- Equities
- MOR Stock